QCI Asset Management’s VanEck Biotech ETF BBH Stock Holding History

QCI Asset Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25	Closed	-$3K	–	595
2019 Q4	$3K	Hold	25	–	–	﹤0.01%	521
2019 Q3	$3K	Hold	25	–	–	﹤0.01%	508
2019 Q2	$3K	Hold	25	–	–	﹤0.01%	545
2019 Q1	$3K	Hold	25	–	–	﹤0.01%	533
2018 Q4	$3K	Hold	25	–	–	﹤0.01%	531
2018 Q3	$3K	Hold	25	–	–	﹤0.01%	531
2018 Q2	$3K	Hold	25	–	–	﹤0.01%	507
2018 Q1	$3K	Hold	25	–	–	﹤0.01%	538
2017 Q4	$3K	Hold	25	–	–	﹤0.01%	551
2017 Q3	$3K	Hold	25	–	–	﹤0.01%	491
2017 Q2	$3K	Hold	25	–	–	﹤0.01%	562
2017 Q1	$3K	Hold	25	–	–	﹤0.01%	491
2016 Q4	$3K	Buy	+25	New	+$2.72K	﹤0.01%	455

Other funds holding BBH

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

QCI Asset Management's BBH Position: Q1 2020 in Review

QCI Asset Management sold out of VanEck Biotech ETF (BBH) in Q1 2020, closing a stake of 25 shares — an estimated $3K sold.

QCI Asset Management first reported a position in BBH in Q4 2016 and held it in 13 quarters. The position peaked at $3K in Q4 2019. 83 funds tracked by Wall St. Rank hold BBH as of Q1 2020.

QCI Asset Management reported no remaining VanEck Biotech ETF position as of Q1 2020 after selling out during the quarter.
QCI Asset Management sold 25 VanEck Biotech ETF shares in Q1 2020, an estimated $3K.
QCI Asset Management first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 13 quarters.
QCI Asset Management's VanEck Biotech ETF position peaked at $3K in Q4 2019.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2020.

Based on QCI Asset Management's 13F filing for Q1 2020, filed 14 May 2020.